TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
cbdMD ( (YCBD) ) has provided an update.
On May 6, 2025, cbdMD executed significant changes to its stock structure. The company converted its 8% Series A Cumulative Convertible Preferred Stock into 65,000,000 shares of Common Stock, following shareholder approval on April 10, 2025. This conversion ceased dividend accruals and trading of the Preferred Stock on the NYSE American. Additionally, cbdMD implemented a one-for-8 reverse stock split of its Common Stock, effective immediately after the conversion, which also received shareholder approval. This split adjusted the CUSIP number and affected all shareholders uniformly, ensuring no fractional shares were issued.
Spark’s Take on YCBD Stock
According to Spark, TipRanks’ AI Analyst, YCBD is a Neutral.
cbdMD’s overall score reflects significant financial performance challenges with high leverage and negative cash flows. Despite a positive earnings call indicating a financial turnaround and achieving profitability, technical indicators suggest a bearish trend. Valuation remains a concern with negative P/E and no dividend. The company’s need to stabilize cash flows and manage liabilities is critical for future improvement.
To see Spark’s full report on YCBD stock, click here.
More about cbdMD
Average Trading Volume: 849,477
Technical Sentiment Signal: Sell
Current Market Cap: $801.6K
Find detailed analytics on YCBD stock on TipRanks’ Stock Analysis page.